Literature DB >> 17283224

Role of nitric oxide in alpha-melanocyte-stimulating hormone-induced hypotension in the nucleus tractus solitarii of the spontaneously hypertensive rats.

Ming-Hong Tai1, Wen-Tsan Weng, Wan-Chen Lo, Julie Y H Chan, Che-Jen Lin, Hing-Chung Lam, Ching-Jiunn Tseng.   

Abstract

Pro-opiomelanocortin (POMC) is expressed in the nucleus tractus solitarii (NTS) of the brainstem, where nitric oxide (NO) plays an important role in cardiovascular regulation. The POMC-derived neuropeptides and their receptors are important regulators of energy homeostasis and cardiovascular functions in the central nervous system. In this study, we investigated the cardiovascular effect of alpha-melanocyte-stimulating hormone (alpha-MSH), a POMC-derived neuropeptide, and its relationship with NO pathway in the NTS of spontaneously hypertensive rats (SHR). Unilateral microinjection of alpha-MSH (0.3-300 pmol) into the NTS resulted in a dose-dependent hypotension and bradycardia in urethane-anesthetized SHR. The alpha-MSH-induced hypotension was abolished by pretreatment with the antagonist of melanocortin-3/4 receptor (MC-3/4R), Ac-Nle-c[Asp-His-D-Nal(2')-Arg-Trp-Lys]-NH2 (SHU9119). Blockade of cAMP/protein kinase A (PKA), the downstream effector of melanocortin receptors, by previous injection of N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89) also ablated the cardiovascular effect of alpha-MSH. To elucidate the role of NO pathway in alpha-MSH-evoked hypotension, pretreatment with Nomega-nitro-L-arginine methyl ester, a universal inhibitor of nitric-oxide synthase (NOS), partially reversed the depressor and bradycardic effects of alpha-MSH. Furthermore, previous application of the inducible NOS (iNOS) inhibitor, aminoguanidine, but not the neuronal NOS inhibitor, 7-nitroindazole, attenuated the cardiovascular effect of alpha-MSH. Histological analysis revealed the colocalization of MC-4R, but not MC-3R, with iNOS in the NTS of SHR. In summary, intra-NTS injection of alpha-MSH induces hypotension and bradycardia of SHR via MC-4R signaling, which activates cAMP/PKA and iNOS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283224     DOI: 10.1124/jpet.106.118299

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John S Rushing; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

Review 2.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

3.  Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.

Authors:  Anne-Maj S Samuelsson; Amandine Mullier; Nuria Maicas; Nynke R Oosterhuis; Sung Eun Bae; Tatiana V Novoselova; Li F Chan; Joaquim M Pombo; Paul D Taylor; Jaap A Joles; Clive W Coen; Nina Balthasar; Lucilla Poston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-06       Impact factor: 11.205

Review 4.  The brain melanocortin system, sympathetic control, and obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Physiology (Bethesda)       Date:  2014-05

5.  Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.

Authors:  Francesca Vaglini; Carla Pardini; Teresa Di Desidero; Paola Orlandi; Francesco Pasqualetti; Alessandra Ottani; Simone Pacini; Daniela Giuliani; Salvatore Guarini; Guido Bocci
Journal:  Mol Neurobiol       Date:  2017-08-08       Impact factor: 5.590

Review 6.  The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances.

Authors:  Jennifer W Hill; Latrice D Faulkner
Journal:  Neuroendocrinology       Date:  2016-10-11       Impact factor: 4.914

7.  Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Bela Kanyicska; John Dubinion; Elizabeth Brandon; John E Hall
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

8.  Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment.

Authors:  B Shariat-Madar; D Kolte; A Verlangieri; Z Shariat-Madar
Journal:  Diabetes Metab Syndr Obes       Date:  2010-04       Impact factor: 3.168

9.  Characterization of the non-adrenergic/non-cholinergic response to perivascular nerve stimulation in the double-perfused mesenteric bed of the mouse.

Authors:  E Legros; C R Tirapelli; E Carrier; I Brochu; A Fournier; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

10.  Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John S Rushing; Benjamin Pace; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-10       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.